The Niacin Extended-Release Tablets, cataloged under National Stock Number 6505-01-524-9144, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Kos Pharmaceuticals Inc. Government technical data includes 7 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 2 manufacturers, enabling identification through both NSN and commercial part number lookups. 1 verified substitute exists in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-524-9144 |
| Primary Part Number | NDC60598-0001-01 |
| Item Name | Niacin Extended-Release Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Kos Pharmaceuticals Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Administration | ORAL |
| American Hospital Formulary Service Classification Number | 240692 |
| Primary Container Type | BOTTLE |
| Long Action Method | EXTENDED RELEASE |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS NIACIN ACTIVE INGREDIENT |
| Total Primary Container Quantity | 1 |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC60598-0001-01 PRIMARY | Kos Pharmaceuticals Inc (USA) |
| 04-1428 | Defense Logistics Agency Directorate of Medical Materiel Defense Supply Center Philadelphia (USA) |
NSN 6505-01-524-9144 is a Niacin Extended-Release Tablets, manufactured by Kos Pharmaceuticals Inc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-524-9144 has 2 cross-referenced part numbers: NDC60598-0001-01 (Kos Pharmaceuticals Inc), 04-1428 (Defense Logistics Agency Directorate of Medical Materiel Defense Supply Center Philadelphia).
There is 1 known substitute for 6505-01-524-9144: 5905-00-577-9494. Verify interchangeability with system specifications before substitution.
Key specifications for NDC60598-0001-01: Primary Container Content Quantity: 100.000 TABLETS; Administration: ORAL; Special Features: SUSTAINED ACTION NIACIN TABLETS; ITEM IS USED AS AN ADJUNCT TO DIET FOR REDUCTION OF ELEVATED TC, LDL-C, APO B AND TG LEVELS, AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA WHEN THE RESPONSE TO AN APPROPRIATE DIET HAS BEEN INADEQUATE; STORE AT ROOM TEMPERATURE (20 TO 25 DEGREES C OR 68 TO 77 DEGREES F); Part Name Assigned by Controlling Agency: NIACIN EXTENDED RELEASE TABLETS 500 MG BT 100S. 9 total characteristics are documented in the Federal Logistics Information System.